Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

3(60.0%)

Phase 1

1(20.0%)

Phase 4

1(20.0%)

5Total

Phase 2(3)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02102256Phase 1Completed

A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients

Role: collaborator

NCT03613844Phase 2Completed

DHA Brain Delivery Trial

Role: collaborator

NCT02069613Completed

Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)

Role: lead

NCT01463384Phase 2Completed

Minocycline in Patients With Alzheimer's Disease

Role: lead

NCT00753467Phase 2Unknown

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

Role: lead

NCT00941642Phase 4Unknown

Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease

Role: lead

All 6 trials loaded